Home > Our Partners > Quanterix
Quanterix is at the forefront of transforming healthcare through its commitment to precision medicine. Their mission is to revolutionize sick care by enabling earlier disease detection, prevention, and the development of next-generation treatments. Using cutting-edge technology, including the ultrasensitive Simoa® platform, they empower researchers to study biomarkers at unprecedented sensitivity levels, uncovering insights into critical therapeutic areas such as neurology, oncology, cardiology, inflammation, and infectious diseases.
With a strong global presence, Quanterix serves academic and industry customers directly in North America and Europe, and through distributor partnerships worldwide. Their expert team of field scientists and engineers provides robust support to researchers across the globe, ensuring success in their critical work.
Built on a foundation of innovation, collaboration, and scientific excellence, Quanterix is driving the future of healthcare by accelerating the discovery and application of novel biomarkers. They are committed to advancing the science of precision health and transforming the way the world approaches medicine.
A simple blood test that could help identify ALS earlier. That’s the promise of serum neurofilament light chain (NfL), and new data from Washington University reinforces why the assay platform behind it matters.
Revolutionizing Biomarker Detection
Quanterix’s Simoa® technology sets a new gold standard for biomarker sensitivity and precision. Detect proteins at femtogram levels in blood, serum, or plasma, enabling earlier disease diagnosis and groundbreaking research. Trusted across neurology, oncology, cardiology, immunology, and infectious disease, Simoa® drives innovation with ultrasensitive instruments, digital immunoassays, and CLIA-certified labs.
Key Features:
As biomarkers advance toward clinical use, measurement platforms must evolve beyond high-plex experimentation. Precision, automation, and regulatory readiness become essential. Simoa’s workflow, designed for clinical research, supports this transition, helping researchers move from discovery-focused tools toward platforms designed for clinical biomarker measurement.
Simoa® Bead Technology offers unprecedented sensitivity, revolutionizing how researchers study health and disease. By detecting biomarkers at ultra-low levels, it enables powerful insights into critical therapeutic areas such as neurology and oncology. With first-of-its-kind detection capabilities, femto-level sensitivity for early diagnosis, and rapid result delivery, Simoa Bead Technology is setting a new standard for precision in biomarker research.
Simoa® Planar Array Technology simplifies complex biomarker research with its robust and multiplexed analysis capabilities. Designed to address unmet needs in modern research, it combines exceptional flexibility, dynamic range, and precision. With the ability to measure up to 10 biomarkers in a single test, optimized fluid dynamics for enhanced reaction kinetics, and high-quality imaging for reliable results, Simoa Planar Array Technology delivers unparalleled performance for advanced biomarker analysis.
We only need these information to serve you better. Decode Science respects your privacy and will never spam you with unrelated content.
Simply add your details below and get quick access to the brochure.
Simply add your details below and get quick access to the brochure.
Simply add your details below and get quick access to the brochure.
